awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35047223-DA37A473-BE1C-4A10-BCFA-8B86E332E376
Q35047223-DA37A473-BE1C-4A10-BCFA-8B86E332E376
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35047223-DA37A473-BE1C-4A10-BCFA-8B86E332E376
Addition of bevacizumab to three docetaxel regimens as adjuvant therapy for early stage breast cancer.
P2860
Q35047223-DA37A473-BE1C-4A10-BCFA-8B86E332E376
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35047223-DA37A473-BE1C-4A10-BCFA-8B86E332E376
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
59725fa37acf212e2900a09ff34aeaf7dffbab87
P2860
A randomized, phase II, three-arm study of two schedules of ixabepilone or paclitaxel plus bevacizumab as first-line therapy for metastatic breast cancer.